Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Jiang S;Jiang S;Jiang S; Yang H; Yang H; Li M; Li M; Li M
  • Source:
    International journal of molecular sciences [Int J Mol Sci] 2023 Aug 07; Vol. 24 (15). Date of Electronic Publication: 2023 Aug 07.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel, Switzerland : MDPI, [2000-
    • Subject Terms:
    • Abstract:
      Lysophosphatidic acid (LPA) is a bioactive phospholipid that regulates physiological and pathological processes in numerous cell biological functions, including cell migration, apoptosis, and proliferation. Macrophages are found in most human tissues and have multiple physiological and pathological functions. There is growing evidence that LPA signaling plays a significant role in the physiological function of macrophages and accelerates the development of diseases caused by macrophage dysfunction and inflammation, such as inflammation-related diseases, cancer, atherosclerosis, and fibrosis. In this review, we summarize the roles of LPA in macrophages, analyze numerous macrophage- and inflammation-associated diseases triggered by LPA, and discuss LPA-targeting therapeutic strategies.
    • References:
      Am J Respir Cell Mol Biol. 2012 Nov;47(5):566-74. (PMID: 22744859)
      Atherosclerosis. 2019 Nov;290:19-30. (PMID: 31557675)
      Birth Defects Res A Clin Mol Teratol. 2014 Mar;100(3):240-6. (PMID: 24616323)
      Trends Biochem Sci. 2005 Oct;30(10):542-50. (PMID: 16125936)
      J Leukoc Biol. 2019 Dec;106(6):1285-1301. (PMID: 31335985)
      Biochim Biophys Acta Mol Cell Biol Lipids. 2020 May;1865(5):158641. (PMID: 32004685)
      Biochim Biophys Acta. 2008 Sep;1781(9):513-8. (PMID: 18621144)
      Am J Pathol. 2006 Apr;168(4):1385-95. (PMID: 16565511)
      Nat Med. 2011 Nov 07;17(11):1410-22. (PMID: 22064431)
      Int J Mol Sci. 2021 Jun 29;22(13):. (PMID: 34209703)
      J Biol Chem. 2007 Feb 23;282(8):5814-24. (PMID: 17172642)
      J Lipid Res. 2019 May;60(5):972-980. (PMID: 30796085)
      Expert Opin Ther Targets. 2018 Feb;22(2):177-189. (PMID: 29168406)
      Lab Invest. 2013 May;93(5):508-19. (PMID: 23478591)
      Am J Respir Cell Mol Biol. 2013 Dec;49(6):912-22. (PMID: 23808384)
      J Biol Chem. 2006 Aug 18;281(33):23589-97. (PMID: 16774927)
      Semin Fetal Neonatal Med. 2010 Aug;15(4):223-9. (PMID: 20430708)
      Clin Exp Allergy. 2007 Mar;37(3):311-22. (PMID: 17359381)
      Eur Respir J. 2022 Aug 25;60(2):. (PMID: 35086834)
      J Biol Chem. 2009 Jun 26;284(26):17731-41. (PMID: 19386608)
      J Biol Chem. 2009 Jun 19;284(25):17304-17319. (PMID: 19366702)
      Signal Transduct Target Ther. 2021 Feb 1;6(1):45. (PMID: 33526777)
      Mol Biol Cell. 2008 Dec;19(12):5435-45. (PMID: 18843048)
      Cancer Res. 2006 Aug 15;66(16):7983-90. (PMID: 16912173)
      J Biol Chem. 2003 Jul 11;278(28):25600-6. (PMID: 12724320)
      EMBO Rep. 2020 Oct 5;21(10):e49332. (PMID: 32875703)
      Lab Invest. 2004 Apr;84(4):425-32. (PMID: 14968125)
      Cells. 2020 Jul 22;9(8):. (PMID: 32707926)
      J Neurochem. 2021 Feb;156(4):499-512. (PMID: 32438456)
      Pharmacol Ther. 2019 Dec;204:107404. (PMID: 31472182)
      Cell Signal. 2018 Apr;44:138-147. (PMID: 29329782)
      Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1505-12. (PMID: 22499993)
      Inflammation. 2017 Oct;40(5):1707-1716. (PMID: 28667502)
      J Heart Lung Transplant. 2021 Jan;40(1):12-23. (PMID: 33339555)
      Int J Mol Sci. 2022 Aug 28;23(17):. (PMID: 36077141)
      Biol Psychiatry. 2004 Apr 15;55(8):789-96. (PMID: 15050859)
      N Engl J Med. 2011 Dec 8;365(23):2205-19. (PMID: 22150039)
      J Orthop Res. 2017 Jul;35(7):1539-1547. (PMID: 27505847)
      Nat Rev Immunol. 2013 Oct;13(10):709-21. (PMID: 23995626)
      Front Oncol. 2020 Jun 10;10:846. (PMID: 32656075)
      Mol Pain. 2006 Aug 16;2:25. (PMID: 16914035)
      Acta Physiol (Oxf). 2016 Mar;216(3):358-75. (PMID: 26495902)
      Front Physiol. 2017 Apr 27;8:266. (PMID: 28496416)
      Nat Genet. 2008 Mar;40(3):329-34. (PMID: 18297070)
      Arthritis Res Ther. 2007;9(6):223. (PMID: 18177509)
      Brain Pathol. 2011 Mar;21(2):119-29. (PMID: 21054626)
      Blood. 2017 Mar 2;129(9):1177-1183. (PMID: 28069607)
      Mol Ther Methods Clin Dev. 2018 Jun 27;10:17-28. (PMID: 30003117)
      Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7614-9. (PMID: 9636198)
      Annu Rev Biochem. 2004;73:321-54. (PMID: 15189145)
      J Lipid Res. 2014 Jul;55(7):1192-214. (PMID: 24643338)
      Int J Mol Med. 2019 Jul;44(1):67-78. (PMID: 31115486)
      J Biol Chem. 2002 Dec 20;277(51):49982-8. (PMID: 12376530)
      J Immunol. 2012 Apr 15;188(8):3784-90. (PMID: 22427635)
      J Clin Invest. 2004 Dec;114(12):1714-25. (PMID: 15599396)
      J Biol Chem. 1999 Sep 24;274(39):27776-85. (PMID: 10488122)
      Mol Neurobiol. 2021 Feb;58(2):470-482. (PMID: 32974731)
      J Lipid Res. 2009 Apr;50 Suppl:S225-30. (PMID: 19066402)
      Oral Oncol. 2012 Jan;48(1):40-8. (PMID: 21925926)
      J Biomed Sci. 2008 May;15(3):357-63. (PMID: 18038269)
      Innate Immun. 2015 Aug;21(6):635-46. (PMID: 25783839)
      Ann Rheum Dis. 2014 Jan;73(1):298-305. (PMID: 23486415)
      J Mol Med (Berl). 2020 Dec;98(12):1781-1794. (PMID: 33128578)
      J Cell Biol. 1996 Nov;135(4):1071-83. (PMID: 8922387)
      J Cell Biol. 2001 Jul 9;154(1):147-60. (PMID: 11448997)
      J Immunol. 2008 Oct 1;181(7):5111-9. (PMID: 18802115)
      Med Oncol. 2022 Jan 4;39(2):17. (PMID: 34982278)
      Nature. 2005 May 5;435(7038):104-8. (PMID: 15875025)
      J Biol Chem. 2002 Dec 13;277(50):48737-44. (PMID: 12354767)
      Stem Cell Reports. 2016 Apr 12;6(4):552-565. (PMID: 27050949)
      Cancers (Basel). 2018 Mar 15;10(3):. (PMID: 29543710)
      J Biol Chem. 2017 Sep 1;292(35):14391-14400. (PMID: 28705936)
      Nature. 2017 Aug 17;548(7667):356-360. (PMID: 28792932)
      Gastroenterology. 2010 Feb;138(2):649-58. (PMID: 19800338)
      Immunol Rev. 2010 Jan;233(1):301-12. (PMID: 20193007)
      Curr Atheroscler Rep. 2011 Apr;13(2):162-9. (PMID: 21271310)
      Mol Pharmacol. 2008 Feb;73(2):587-600. (PMID: 18006645)
      J Clin Invest. 1998 Aug 15;102(4):716-27. (PMID: 9710440)
      FASEB J. 2016 Aug;30(8):2885-98. (PMID: 27178323)
      J Lipid Res. 2013 May;54(5):1265-74. (PMID: 23396975)
      Int J Mol Sci. 2020 Nov 14;21(22):. (PMID: 33202644)
      Cancer Res. 1994 Oct 15;54(20):5455-63. (PMID: 7923179)
      J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 1:80-2. (PMID: 21892878)
      Circulation. 2007 Nov 6;116(19):2173-81. (PMID: 17967778)
      Proc Am Thorac Soc. 2012 Jul;9(3):111-6. (PMID: 22802283)
      Nurs Stand. 2011 Oct 5-11;26(5):48-56; quiz 58. (PMID: 22073746)
      Arthritis Rheumatol. 2018 Oct;70(10):1634-1643. (PMID: 29732731)
      Mol Cell Biol. 2006 Jul;26(13):5015-22. (PMID: 16782887)
      Oncogenesis. 2014 Oct 06;3:e120. (PMID: 25285406)
      J Immunol. 2004 Apr 1;172(7):4480-5. (PMID: 15034064)
      Nature. 1990 Oct 18;347(6294):645-50. (PMID: 2129546)
      Annu Rev Immunol. 2017 Apr 26;35:441-468. (PMID: 28226226)
      Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L66-74. (PMID: 16199434)
      Nat Med. 2011 Mar;17(3):320-9. (PMID: 21383745)
      Free Radic Res. 2015;49(11):1362-70. (PMID: 26178778)
      Neuropharmacology. 2019 Sep 1;155:150-161. (PMID: 31145906)
      Int J Mol Sci. 2019 Apr 29;20(9):. (PMID: 31035435)
      Signal Transduct Target Ther. 2020 Mar 27;5(1):24. (PMID: 32296017)
      Neuropharmacology. 2017 Feb;113(Pt B):608-617. (PMID: 27059127)
      Endocrinology. 2005 Aug;146(8):3387-400. (PMID: 15878967)
      Front Immunol. 2018 Nov 27;9:2733. (PMID: 30538701)
      J Biol Chem. 2012 May 18;287(21):17608-17617. (PMID: 22461625)
      Dev Dyn. 2008 Nov;237(11):3280-94. (PMID: 18924241)
      Nature. 2011 May 19;473(7347):317-25. (PMID: 21593864)
      Cell Metab. 2011 May 4;13(5):592-600. (PMID: 21531341)
      Biomark Med. 2016;10(2):123-35. (PMID: 26808693)
      Front Physiol. 2017 Mar 22;8:155. (PMID: 28382003)
      Mol Pharmacol. 2000 Nov;58(5):895-902. (PMID: 11040035)
      Hypertension. 2015 Dec;66(6):1220-6. (PMID: 26483345)
      Br J Pharmacol. 2011 Oct;164(4):1079-106. (PMID: 21371012)
      Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11779-84. (PMID: 15280540)
      Mol Cancer Ther. 2020 Jan;19(1):63-74. (PMID: 31548293)
      Annu Rev Pharmacol Toxicol. 2001;41:507-34. (PMID: 11264467)
      Am J Respir Cell Mol Biol. 2012 Mar;46(3):355-64. (PMID: 22021336)
      Mol Pharmacol. 2003 Nov;64(5):1199-209. (PMID: 14573770)
      Exp Mol Pathol. 2014 Apr;96(2):242-9. (PMID: 24594117)
      Biochem Biophys Res Commun. 2017 Sep 23;491(3):587-594. (PMID: 28765047)
      J Exp Med. 2012 May 7;209(5):925-33. (PMID: 22493518)
      N Engl J Med. 2018 Jan 11;378(2):169-180. (PMID: 29320652)
      Am J Respir Crit Care Med. 2013 Oct 15;188(8):928-40. (PMID: 24050723)
      Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2261-2272. (PMID: 31533471)
      Respir Res. 2022 Mar 18;23(1):61. (PMID: 35303880)
      PLoS One. 2020 Apr 2;15(4):e0226050. (PMID: 32240164)
      Mol Cancer. 2017 Feb 8;16(1):36. (PMID: 28178994)
      Curr Opin Pharmacol. 2017 Aug;35:12-19. (PMID: 28538141)
      Nature. 2013 Apr 25;496(7446):445-55. (PMID: 23619691)
      Cancer Metastasis Rev. 2006 Sep;25(3):481-91. (PMID: 17103050)
      Nat Med. 2004 Jul;10(7):712-8. (PMID: 15195086)
      Cancer Res. 2004 Oct 1;64(19):7022-9. (PMID: 15466195)
      Biochem Biophys Res Commun. 1991 Feb 28;175(1):339-43. (PMID: 1998517)
      Nat Immunol. 2010 Oct;11(10):889-96. (PMID: 20856220)
      FEBS Lett. 2014 Aug 19;588(16):2712-27. (PMID: 24560789)
      J Steroid Biochem Mol Biol. 2015 Sep;153:72-9. (PMID: 25910582)
      Nat Med. 2008 Jan;14(1):45-54. (PMID: 18066075)
      J Natl Cancer Inst. 2008 Nov 19;100(22):1630-42. (PMID: 19001604)
      Arthritis Rheum. 2010 Aug;62(8):2294-302. (PMID: 20506288)
      J Pathol. 2000 Oct;192(2):150-8. (PMID: 11004690)
      Biochim Biophys Acta. 2004 Jun 1;1682(1-3):112-9. (PMID: 15158762)
      J Biol Chem. 2011 Apr 1;286(13):11696-706. (PMID: 21262967)
      J Cell Mol Med. 2020 Nov;24(21):12234-12245. (PMID: 32969153)
      J Biol Chem. 2014 Aug 29;289(35):24020-9. (PMID: 25074931)
      J Clin Invest. 2011 Jul;121(7):2736-49. (PMID: 21670502)
      Prostaglandins Other Lipid Mediat. 2008 Dec;87(1-4):20-5. (PMID: 18585471)
      J Biol Chem. 2007 Feb 16;282(7):4310-4317. (PMID: 17166850)
      PLoS One. 2010 Mar 17;5(3):e9741. (PMID: 20305819)
    • Grant Information:
      92057119 National Natural Science Foundation of China; 23ZR1408200 Shanghai Natural Science Foundation; 22YF1404000 Shanghai Sailing Program; JIF157602 Program for Zhuoxue of Fudan University; DGF828013/032 Training Program for Famous Medical Teachers of Fudan University
    • Contributed Indexing:
      Keywords: atherosclerosis; fibrosis; inflammation; lysophosphatidic acid; lysophosphatidic acid receptor; macrophage
    • Accession Number:
      PG6M3969SG (lysophosphatidic acid)
      0 (Receptors, Lysophosphatidic Acid)
      0 (Lysophospholipids)
    • Publication Date:
      Date Created: 20230812 Date Completed: 20230814 Latest Revision: 20230814
    • Publication Date:
      20250114
    • Accession Number:
      PMC10419859
    • Accession Number:
      10.3390/ijms241512524
    • Accession Number:
      37569902